top of page

Alison Finger


Alison is the Principal at Auburn House Consulting, LLC and serves on the Board of ADMA Biologics, Inc. and is an Advisor at Quantile Health. She previously held Board positions at Decibel Therapeutics and Vascular Biogenics and served as Chief Commercial Officer at Bluebird Bio. Ms. Finger also spent over two decades at Bristol-Myers Squibb serving as Vice President of Global Commercialization for Virology, Hematology and the Alzheimer’s Disease and Neuroscience programs in addition to her role as Managing Director of Australia and New Zealand. Ms. Finger earned her MBA from Duke University’s Fuqua School of Business and a B.A. in English from St. Lawrence University.

bottom of page